Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,908 | -24,921 | -10,932 | -41,246 | -29,733 |
| Depreciation Amortization | 1,266 | 776 | 387 | 825 | 464 |
| Accounts receivable | N/A | N/A | N/A | N/A | 148 |
| Accounts payable and accrued liabilities | 523 | -372 | -161 | N/A | -503 |
| Other Working Capital | 136,145 | -581 | -1,994 | 56,687 | 56,744 |
| Other Operating Activity | 3,172 | 1,629 | 643 | 1,639 | 1,586 |
| Operating Cash Flow | $108,198 | $-23,469 | $-12,057 | $17,905 | $28,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,659 | -5,250 | -1,395 | -532 | -333 |
| Purchase Of Investment | -460,939 | -110,527 | -36,008 | N/A | -78,112 |
| Sale Of Investment | 50,000 | 31,500 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -15,954 | 0 |
| Investing Cash Flow | $-418,598 | $-84,277 | $-37,403 | $-16,486 | $-78,445 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -402 | -293 | -142 | N/A | -253 |
| Common Stock Issued | 196,413 | 29 | N/A | N/A | 46 |
| Other Financing Activity | 92,981 | 92,981 | 93,262 | 34,911 | 14,025 |
| Financing Cash Flow | $288,992 | $92,717 | $93,120 | $34,911 | $13,818 |
| Beginning Cash Position | 77,789 | 77,789 | 77,789 | 41,459 | 41,459 |
| End Cash Position | 56,381 | 62,760 | 121,449 | 77,789 | 5,538 |
| Net Cash Flow | $-21,408 | $-15,029 | $43,660 | $36,330 | $-35,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | 108,198 | -23,469 | -12,057 | 17,905 | 28,706 |
| Capital Expenditure | -7,659 | -5,250 | -1,395 | N/A | -333 |
| Free Cash Flow | 100,539 | -28,719 | -13,452 | 17,905 | 28,373 |